Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of TRH (protirelin) in intensive care patients: dose-finding study
2016-001006-41Phase 2Active
- Sponsor
- Amsterdam University Medical Center
- Start
- Aug 2016
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2 trial of thyrotropin-releasing hormone in euthyroid sick syndrome (NTIS), sponsored by Amsterdam University Medical Center. Primary endpoint: Plasma thyroid hormone levels (primary). Started Aug 2016; status: active.
02
Drugs
thyrotropin-releasing hormone
03
Conditions
euthyroid sick syndrome (NTIS)
Beyond the preview
Go deeper on 2016-001006-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001006-41.